Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Medical Marijuana I (OP: MJNA )

0.0003 -0.0001 (-25.00%)
Streaming Delayed Price Updated: 3:57 PM EST, Dec 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 37,442,525
Open 0.0004
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0004
Today's Range 0.0003 - 0.0004
52wk Range 0.0001 - 0.0043
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Cannabis Stocks Collapse After Trump Win: Major Players See Double-Digit Declines At Wednesday's Close
Following Trump's presidential election victory, the cannabis sector took a sharp downturn. Here's a summary of what happened today. 
Via Benzinga
Topics Cannabis Government
Exposures Cannabis Political
Supreme Court Split Over Trucker Fired For Unintentional CBD Use, Suing Under RICO Act
U.S. Supreme Court considering RICO case involving fired truck driver claiming injury from CBD product, divided on implications of ruling. 
Via Benzinga

Performance

YTD
-91.43%
-91.43%
1 Month
-50.00%
-50.00%
3 Month
-70.00%
-70.00%
6 Month
-81.25%
-81.25%
1 Year
-92.11%
-92.11%

More News

Read More
Cannabis Stocks React To Trump's Marijuana Comments: See Which Ones Posted Solid Gains
Via Benzinga
Topics Cannabis Government
Exposures Cannabis Political
Trump's Marijuana Support Could Ignite Stock Surge – Are You Positioned To Benefit?
Via Benzinga
Topics Cannabis Government
Exposures Cannabis Political
Medical Marijuana, Inc. Portfolio Investment Company Neuropathix Announces Grant Award for Parkinson's Research
Via NewMediaWire
Topics Cannabis
Exposures Cannabis
Medical Marijuana, Inc. Portfolio Investment Company Neuropathix Announces Grant Award for Parkinson's Research
Via TheNewswire.com
Topics Cannabis
Exposures Cannabis
Easy-To-Trade Cannabis Stocks: Insights Into How Trading Activity Affects These Investments
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Stocks Under $2: Why Are These Small-Cap Shares Up While Broader Sector Is In The Red?
Via Benzinga
Topics Cannabis
Exposures Cannabis
NY Supreme Court's Landmark Ruling Upholds Medical Marijuana Patient's Rights Under Human Rights Law
Via Benzinga
Topics Cannabis
Exposures Cannabis
Medical Marijuana, Inc. Kannaway Division Completes Acquisition of KZ1 Network Marketing Company
From Medical Marijuana, Inc.
Via Business Wire
Historic Ruling To Legalize Cannabis Cultivation In Brazil: These Weed Companies Will Likely Benefit
Via Benzinga
Key Marijuana Executive Changes You Should Know About, New Appointments & More
Via Benzinga
Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
Via NewMediaWire
Topics Cannabis
Exposures Cannabis
CBD For Traumatic Brain Injuries? Oral Administration Reduces Levels Of Neuronal Death In Animal Model, New Study
Via Benzinga
Medical Marijuana, Inc. Participates in Preclinical Research Study on Therapeutic Benefits of CBD on Traumatic Brain Injuries
Via NewMediaWire
Topics Cannabis Economy
Exposures Cannabis Supply Chain
Medical Marijuana Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
Via Benzinga
Medical Marijuana, Inc. Subsidiary HempMeds Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
Via NewMediaWire
Topics Cannabis Economy Lawsuit
Exposures Cannabis Financial Legal
Key Cannabis Exec Changes You Need To Know About: Dutchie Taps New CEO, Illinois' New Cannabis Officer & More
Via Benzinga
Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
Via NewMediaWire
Topics Cannabis Economy
Exposures Cannabis Supply Chain
Medical Marijuana Q3 Revenue Declines 37% Sequentially, Here Are The Details
Via Benzinga
Medical Marijuana, Inc. Reports $4.9 Million in Net Revenue in 2022 Third Quarter Financial and Operational Results
Via NewMediaWire
Topics Cannabis Economy
Exposures Cannabis Supply Chain
Medical Marijuana, Inc. Subsidiary HempMeds Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
Via NewMediaWire
Topics Cannabis Economy
Exposures Cannabis Supply Chain
Argentina's 'Cannabis Conicet' Public Company Seeks To Strengthen The Industry In South America
Via Benzinga
Medical Marijuana, Inc. Subsidiary HempMeds Mexico Celebrates Successful Sponsorship of 2022 XII Latin American Congress of Epilepsy in Medellin, Colombia
Via NewMediaWire
Topics Cannabis Economy
Exposures Cannabis Supply Chain
Medical Marijuana, Inc. Subsidiary HempMeds Mexico Undertakes Promising CBD Research For Parkinson's Treatment
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.